Genetic Testing with Family History of Pancreatic Cancer
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 24-006906
NCT ID: NCT06744595
Sponsor Protocol Number: 24-006906
About this study
The purpose of this study is perform HOUSES index analysis on 500 patients with a first-degree relative diagnosed with pancreatic cancer to see if there is a correlation with the National Comprehensive Cancer Network (NCCN) criteria. A subset of 40 patients, who did not have appropriate NCCN intervention (the opportunity to have a genetic consultation to consider genetic testing) will prospectively be offered this opportunity. This subset of patients will also be surveyed on their family hisotry and knowledge and experiences of genetic consults/testing to better understand their decision-making when offered genetic counseling and testing.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Age: 18-75 years of age
- First-degree relative with pancreatic cancer listed in the EPIC family history tool
- Active patient at MCF (visits within 1/1/2023-12/31/2023 to Family Medicine and/or Gastroenterology and Hepatology)
Exclusion Criteria:
- Patients not meeting the inclusion criteria as defined above.
- Patients with an active or past history of pancreatic cancer.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 07/16/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Jacksonville, Fla.
Mayo Clinic principal investigator Adrianna Clapp, M.D. |
Open for enrollment |
Contact information:
Clinical Studies Unit
(904) 953-2255
|
More information
Publications
Publications are currently not available